By Nigam Arora & Dr. Natasha Arora
Signal Limited is a Signal(s) with a great record in similar situations but does not meet all of the stringent criteria for a Signal. Typically Signal Limited has higher risk-reward compared to a Signal over the short term.
DraftKings (DKNG) is long from $17.74. It is trading at $43.62 as of this writing. This represents a profit of 146%.
The Super Bowl is ahead this weekend. Record Super Bowl betting is expected.
The target zone is being raised to $63 – $68.
What To Do Now
For tracking purposes, the stock will continue to be held. However, understand that there may a “sell the news” reaction on Monday. For this reason, depending upon the rest of your portfolio, there is merit to taking partial profits on a small quantity.
Those not in the stock may consider waiting for a new signal on the Real Time Feed when the air clears after potential record Super Bowl betting.
You missed out on the last 146% gain. Do not miss out when new signals are given on DKNG and other sports betting companies such as MGM Resorts (MGM), Caesars Entertainment (CZR), and PENN Entertainment (PENN).
To take a free 30-day trial to paid services to gain access to more opportunities, please click here.
This post was just published on ZYX Buy Change Alert.
Markets can generate substantial wealth for knowledgeable investors. NOW YOU TOO CAN ALSO SPECTACULARLY SUCCEED AT MEETING YOUR GOALS WITH THE HELP OF THE ARORA REPORT. You are receiving less than 2% of the content from our paid services. …TO RECEIVE REMAINING 98% INCLUDING MANY ATTRACTIVE INVESTMENT OPPORTUNITIES, TAKE A FREE
TRIAL TO PAID SERVICES.
Please click here to take advantage of a FREE 30 day trial.

Nigam Arora
Nigam Arora is known for his accurate stock market calls. Nigam is a distinguished master of the macro. He is a popular columnist with over 100 million page views, an engineer, and nuclear physicist by background. Nigam has founded two Inc. 500 fastest growing companies and has been involved in over 50 entrepreneurial ventures. He is the developer of Theory ZYX of Successful Change Management and is the author of the book on Theory ZYX, as well as the developer of the ZYX Change Method for Investing.

Dr. Natasha Arora
Dr. Natasha Arora has significant expertise in investment analysis especially biotech, healthcare, and technology. Natasha is a graduate of Harvard Medical School followed by a postdoc at MIT. She has published several peer reviewed research papers in top science journals.